Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether ultrasound can help detect thyroid problems in unborn babies from women who have thyroid disease. The researchers want to find out if they can diagnose any thyroid issues early on by measuring certain parameters of the fetal thyroid using ultrasound. This study is specifically looking at women between 14 and 37 weeks pregnant who are generally healthy and have uncomplicated pregnancies.

To join the study, participants need to be women aged 18 to 45 who can understand Italian and are willing to give their consent to participate. They will be followed for the entire pregnancy until delivery. However, women who smoke, have certain health conditions, are pregnant with twins, or have specific fetal issues will not be eligible. Participants can expect to undergo ultrasound examinations during their regular prenatal visits, and their contributions may help improve understanding and management of fetal thyroid health in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Participants between 14 and 37 gestational weeks, who will be followed for the entire period of pregnancy, up to delivery, at the same enrolling center
• • Obtaining informed consent for participation in the study
• • Maternal age between 18 and 45 years (extremes included)
• • Participants with good understanding of the Italian language
• Exclusion Criteria:
• • Smoking participants
• • Patients with BMI\>30
• • Absence of correct dating of pregnancy within the first trimester
• • Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth)
• • Twin pregnancy
• • Only for the low obstetric risk group of patients: Fetus with malformative pathology